Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Eculizumab

EU orphan designation number: EU/3/09/653   
Active ingredient: Eculizumab
Indication: Treatment of atypical haemolytic uremic syndrome
Sponsor: Alexion Europe SAS
1-15 avenue Edouard Belin, 92500 Rueil-Malmaison, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2009 Orphan Designation EMEA/OD/027/09 (2009)6029 of 24/07/2009
15/10/2009 Change of address of sponsor
20/02/2015 Change of address of sponsor